CLDN18: Claudin-18
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Involved in alveolar fluid homeostasis via regulation of alveolar epithelial tight junction composition and therefore ion transport and solute permeability, potentially via downstream regulation of the actin cytoskeleton organization and beta-2-adrenergic signaling.
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Zolbetuximab | Approved | Claudin-18 binding agent | Binding agent | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Gastric adenocarcinoma
- 0.50
- Gastroesophageal junction adenocarcinoma
- 0.49
- Gastric cancer
- 0.49
- Neoplasm
- 0.40
- Gastric neoplasm
- 0.38
- Neoplasm of esophagus
- 0.37
- Type 2 diabetes mellitus
- 0.25
- Liver disorder
- 0.20
- Retinal disorder
- 0.19
- Aganglionic megacolon
- 0.12
Drugs and mechanisms are from ChEMBL CHEMBL3712859 (CC BY-SA 3.0). Gene name, function (UniProt P56856, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets